Stock listing

GLENMARK Stock Price, News, Filings & Events — Glenmark Pharmaceuticals Limited

Selected listing: GLENMARK · NSE · INR · IN

This page tracks Glenmark Pharmaceuticals Limited's GLENMARK:NSE listing on NSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLENMARK:NSE. GLENMARK:NSE is the stock-level entry point for investors researching Glenmark Pharmaceuticals Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Glenmark Pharmaceuticals Limited, trading under the ticker GLENMARK, is a public company based in India with a market capitalization of approximately $6.7 billion. The company specializes in the development and manufacturing of a wide range of pharmaceutical products. Glenmark is committed to innovation and improving health outcomes through its diverse portfolio.

GLENMARK:NSEINRINUpdated August 21, 2026
Glenmark Pharmaceuticals Limited logo
Ticker
GLENMARK:NSE
Asset type
Stock
Market cap
$6.85B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NSE
Currency
INR

Glenmark Pharmaceuticals Limited GLENMARK:NSE stock context

This page tracks Glenmark Pharmaceuticals Limited's GLENMARK:NSE listing on NSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLENMARK:NSE. GLENMARK:NSE is the stock-level entry point for investors researching Glenmark Pharmaceuticals Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Glenmark Pharmaceuticals Limited, trading under the ticker GLENMARK, is a public company based in India with a market capitalization of approximately $6.7 billion. The company specializes in the development and manufacturing of a wide range of pharmaceutical products. Glenmark is committed to innovation and improving health outcomes through its diverse portfolio.

Latest news from Glenmark Pharmaceuticals Limited

All Glenmark Pharmaceuticals Limited news →

Research Glenmark Pharmaceuticals Limited

Alternate listings